Host Long Noncoding RNAs as Key Players in Mycobacteria-Host Interactions
- PMID: 39770858
- PMCID: PMC11728548
- DOI: 10.3390/microorganisms12122656
Host Long Noncoding RNAs as Key Players in Mycobacteria-Host Interactions
Abstract
Mycobacterial infections, caused by various species within the Mycobacterium genus, remain one of the main challenges to global health across the world. Understanding the complex interplay between the host and mycobacterial pathogens is essential for developing effective diagnostic and therapeutic strategies. Host long noncoding RNAs (lncRNAs) have emerged as key regulators in cellular response to bacterial infections within host cells. This review provides an overview of the intricate relationship between mycobacterial infections and host lncRNAs in the context of Mycobacterium tuberculosis and non-tuberculous mycobacterium (NTM) infections. Accumulation of evidence indicates that host lncRNAs play a critical role in regulating cellular response to mycobacterial infection within host cells, such as macrophages, the primary host cells for mycobacterial intracellular survival. The expression of specific host lncRNAs has been implicated in the pathogenesis of mycobacterial infections, providing potential targets for the development of novel host-directed therapies and biomarkers for TB diagnosis. In summary, this review aims to highlight the current state of knowledge regarding the involvement of host lncRNAs in mycobacterial infections. It also emphasizes their potential application as novel diagnostic biomarkers and therapeutic targets.
Keywords: Mycobacterium bovis BCG; Mycobacterium tuberculosis; host cells; lncRNAs; long noncoding RNAs; macrophages; mycobacterial infections; non-tuberculous mycobacteria.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.Microbiol Spectr. 2023 Aug 17;11(4):e0160623. doi: 10.1128/spectrum.01606-23. Epub 2023 Jun 28. Microbiol Spectr. 2023. PMID: 37378523 Free PMC article.
-
[Frontier of mycobacterium research--host vs. mycobacterium].Kekkaku. 2005 Sep;80(9):613-29. Kekkaku. 2005. PMID: 16245793 Japanese.
-
The Role of microRNAs and Long Non-Coding RNAs in the Regulation of the Immune Response to Mycobacterium tuberculosis Infection.Front Immunol. 2021 Jun 24;12:687962. doi: 10.3389/fimmu.2021.687962. eCollection 2021. Front Immunol. 2021. PMID: 34248974 Free PMC article. Review.
-
Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy.Microbiol Spectr. 2024 Aug 6;12(8):e0016724. doi: 10.1128/spectrum.00167-24. Epub 2024 Jun 25. Microbiol Spectr. 2024. PMID: 38916320 Free PMC article.
-
Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities.Front Immunol. 2021 Sep 23;12:747387. doi: 10.3389/fimmu.2021.747387. eCollection 2021. Front Immunol. 2021. PMID: 34630426 Free PMC article. Review.
Cited by
-
LncRNA C5orf64 polymorphisms (rs12518552 and rs2950218) decreases pulmonary tuberculosis susceptibility.Ann Med. 2025 Dec;57(1):2523557. doi: 10.1080/07853890.2025.2523557. Epub 2025 Jun 28. Ann Med. 2025. PMID: 40580075 Free PMC article.
-
Advances in Host-Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention.Int J Mol Sci. 2025 Feb 14;26(4):1621. doi: 10.3390/ijms26041621. Int J Mol Sci. 2025. PMID: 40004082 Free PMC article. Review.
-
Microvesicles Derived from Human Bronchial Epithelial Cells Regulate Macrophage Activation During Mycobacterium abscessus Infection.J Proteome Res. 2025 May 2;24(5):2291-2301. doi: 10.1021/acs.jproteome.4c00827. Epub 2025 Mar 28. J Proteome Res. 2025. PMID: 40153482 Free PMC article.
References
-
- Daley C.L., Iaccarino J.M., Lange C., Cambau E., Wallace R.J., Andrejak C., Böttger E.C., Brozek J., Griffith D.E., Guglielmetti L., et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin. Infect. Dis. 2020;71:905–913. doi: 10.1093/cid/ciaa1125. - DOI - PMC - PubMed
-
- Floto R.A., Olivier K.N., Saiman L., Daley C.L., Herrmann J.-L., Nick J.A., Noone P.G., Bilton D., Corris P., Gibson R.L., et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71:i1–i22. doi: 10.1136/thoraxjnl-2015-207360. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources